Refine
Year of publication
- 2011 (2047) (remove)
Document Type
- Article (1322)
- Doctoral Thesis (289)
- Monograph/Edited Volume (165)
- Review (96)
- Postprint (67)
- Conference Proceeding (29)
- Other (21)
- Master's Thesis (15)
- Part of Periodical (13)
- Preprint (9)
Language
Keywords
- Deutschland (17)
- Bürgerschaft (16)
- Germany (16)
- Integration (16)
- International Politics (16)
- Internationale Politik (16)
- Migration (16)
- Politische Theorie (16)
- Afghanistan (15)
- Friedens- und Konfliktforschung (14)
Institute
- Institut für Biochemie und Biologie (242)
- Institut für Physik und Astronomie (187)
- Institut für Chemie (176)
- Institut für Geowissenschaften (141)
- Institut für Romanistik (141)
- Wirtschaftswissenschaften (104)
- Department Psychologie (79)
- Sozialwissenschaften (73)
- MenschenRechtsZentrum (72)
- WeltTrends e.V. Potsdam (70)
- Historisches Institut (66)
- Department Linguistik (65)
- Institut für Informatik und Computational Science (54)
- Institut für Ernährungswissenschaft (52)
- Institut für Slavistik (52)
- Institut für Anglistik und Amerikanistik (49)
- Institut für Germanistik (46)
- Institut für Jüdische Studien und Religionswissenschaft (41)
- Institut für Mathematik (38)
- Hasso-Plattner-Institut für Digital Engineering gGmbH (33)
- Vereinigung für Jüdische Studien e. V. (32)
- Extern (31)
- Philosophische Fakultät (28)
- Department Sport- und Gesundheitswissenschaften (27)
- Öffentliches Recht (27)
- Bürgerliches Recht (26)
- Department Erziehungswissenschaft (26)
- Institut für Künste und Medien (24)
- Institut für Umweltwissenschaften und Geographie (21)
- Mathematisch-Naturwissenschaftliche Fakultät (18)
- Zentrum für Qualitätsentwicklung in Lehre und Studium (ZfQ) (14)
- Moses Mendelssohn Zentrum für europäisch-jüdische Studien e. V. (13)
- Strafrecht (8)
- Sonderforschungsbereich 632 - Informationsstruktur (6)
- Strukturbereich Bildungswissenschaften (6)
- Humanwissenschaftliche Fakultät (4)
- Institut für Religionswissenschaft (4)
- Wirtschafts- und Sozialwissenschaftliche Fakultät (4)
- Kommunalwissenschaftliches Institut (3)
- Referat für Presse- und Öffentlichkeitsarbeit (3)
- Strukturbereich Kognitionswissenschaften (3)
- Zentrum für Lehrerbildung und Bildungsforschung (ZeLB) (3)
- Fachgruppe Politik- & Verwaltungswissenschaft (2)
- Zentrum für Sprachen und Schlüsselkompetenzen (Zessko) (2)
- Department Grundschulpädagogik (1)
- Fachgruppe Soziologie (1)
- Gleichstellungsbeauftragte (1)
- Institut für Philosophie (1)
- Juristische Fakultät (1)
- Klassische Philologie (1)
- Lehreinheit für Wirtschafts-Arbeit-Technik (1)
- Potsdam Transfer - Zentrum für Gründung, Innovation, Wissens- und Technologietransfer (1)
- Universitätsbibliothek (1)
- Verband für Patholinguistik e. V. (vpl) (1)
Background
Riociguat is the first of a new class of drugs, the soluble guanylate cyclase (sGC) stimulators. Riociguat has a dual mode of action: it sensitizes sGC to the body’s own NO and can also increase sGC activity in the absence of NO. The NO-sGC-pathway is impaired in many cardiovascular diseases such as heart failure, pulmonary hypertension and diabetic nephropathy (DN). DN leads to high cardiovascular morbidity and mortality. There is still a high unmet medical need. The urinary albumin excretion rate is a predictive biomarker for these clinical events. Therefore, we investigated the effect of riociguat, alone and in combination with the angiotensin II receptor antagonist (ARB) telmisartan on the progression of DN in diabetic eNOS knock out mice, a new model closely resembling human pathology.
Methods
Seventy-six male eNOS knockout C57BL/6J mice were divided into 4 groups after receiving intraperitoneal high-dose streptozotocin: telmisartan (1 mg/kg), riociguat (3 mg/kg), riociguat+telmisartan (3 and 1 mg/kg), and vehicle. Fourteen mice were used as non-diabetic controls. After 12 weeks, urine and blood were obtained and blood pressure measured. Glucose concentrations were highly increased and similar in all diabetic groups.
Results
Riociguat, alone (105.2 ± 2.5 mmHg; mean±SEM; n = 14) and in combination with telmisartan (105.0 ± 3.2 mmHg; n = 12), significantly reduced blood pressure versus diabetic controls (117.1 ± 2.2 mmHg; n = 14; p = 0.002 and p = 0.004, respectively), whereas telmisartan alone (111.2 ± 2.6 mmHg) showed a modest blood pressure lowering trend (p = 0.071; n = 14). The effects of single treatment with either riociguat (97.1 ± 15.7 µg/d; n = 13) or telmisartan (97.8 ± 26.4 µg/d; n = 14) did not significantly lower albumin excretion on its own (p = 0.067 and p = 0.101, respectively). However, the combined treatment led to significantly lower urinary albumin excretion (47.3 ± 9.6 µg/d; n = 12) compared to diabetic controls (170.8 ± 34.2 µg/d; n = 13; p = 0.004), and reached levels similar to non-diabetic controls (31.4 ± 10.1 µg/d, n = 12).
Conclusion
Riociguat significantly reduced urinary albumin excretion in diabetic eNOS knock out mice that were refractory to treatment with ARB’s alone. Patients with diabetic nephropathy refractory to treatment with ARB’s have the worst prognosis among all patients with diabetic nephropathy. Our data indicate that additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for patients with diabetic nephropathy resistant to ARB treatment.